text: <unk>  is an antineoplastic that is FDA approved for the treatment of colorectal cancer, gastrointestinal stromal tumors. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include hypertension, mucositis, dysphonia, infection, pain.
option_0: Regorafenib
option_1: Encorafenib
option_2: Brigatinib
option_3: Fostamatinib
option_4: Neratinib
option_5: Dasatinib
option_6: Afatinib
option_7: Vemurafenib